| Application no. and date | 18856299.5 (espacenet) (Federated) (European Patent Register), 20180906 | | Patent/reg. no. and date | DK/EP 3681507, 20240207 | | Publication date | 20200722 | | Priority no. and date | US 201762558004 P, 20170913, US 201862649938 P, 20180329 | | EP pub. no. and date |
EP 3681507 20200722 | | Effective date | | | Applicant/owner | Emmyon, Inc., Minnesota BioBusiness Center
Suite 03-370 "The Hatchery"
221 1st SW
Rochester, MN 55902, US | | Applicant ref. no. | | | Inventor | TALLEY, John J., 6519 Walsh Street
St. Louis, Missouri 63109, US | | Representative | | | Opponent | | | IPC Class | A23L 33/10 (2016.01) , A23L 33/105 (2016.01) , A61K 31/19 (2006.01) , A61K 31/56 (2006.01) , A61P 21/00 (2006.01) , A61P 3/00 (2006.01) , A61P 3/04 (2006.01) , A61P 3/06 (2006.01) , A61P 3/10 (2006.01) , C07C 279/26 (2006.01) , C07C 62/32 (2006.01) | | Title | URSOLIC ACID MORPHOLINE AND DIETHANOLAMINE SALTS | | Int. application no. | US2018049742 | | Int. publication no. | WO2019055280 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
